Project Scope |
Best Practices in Data Standards Implementation Governance will cover the following areas:
|
Project Leads | ||
Ellen Asam, Merck | ellen_asam@merck.com | |
Sandy VanPelt Nguyen, Pfizer | ||
Nicola Newton, PHUSE Project Assistant | )katie@phuse.global | |
Objectives & Deliverables | Timelines | |
| Q22021 Q32021 Q42021 Q22021 | |
| /42021||||||
| ||||||
Project Members | Organisation | |||||
Aimee Basile | Surface Oncology | |||||
Brook (Amanda) Hinkson | Merck | |||||
Carlo Radovsky | Immanant | |||||
Cathy Yang | Roche | |||||
Gayathri Mahadevan | Cytel | |||||
Jennifer Jarvis | Eli Lilly | |||||
Junying Zhang | Gilead | |||||
Ligia Kilinski Cevasco | Jazz Pharmaceuticals | |||||
Parisa Osivand Pour | Industry | |||||
Patrick Genyn | Janssen Research and Development | |||||
Ranvir Singh | Labcorp | |||||
Rie Ichihashi | Sanofi | |||||
Rony Ye | EBSI | |||||
Sathesh Avvaru | PPD | |||||
Tingting Tian | Regeneron | |||||
Titania Dumas-Roberson | Unither Pharmaceuticals | |||||
Todd Bazin | Biogen | |||||
Torsten Petsching | Boehringer Ingelheim2024 | |||||
|
Objectives & Deliverables | Timelines |
White Paper Published | Q4 2024 |
Publish White Paper | Q4 2023 |
Potentially make updates to White Paper following PHUSE Steering Committee and Public Review feedback | Q3 2023 |